期刊文献+

奎硫平与利培酮治疗73例首发精神分裂症的对照研究 被引量:17

暂未订购
导出
摘要 目的研究奎硫平与利培酮治疗首发精神分裂症的疗效和安全性。方法将73例在重庆市长寿区精神病医院精神专科医院接受住院治疗的首发精神分裂症患者分为两组,总研究疗程4周。用阳性症状和阴性症状量表(PANSS)进行疗效评定,用不良反应量表(TESS)评估药物不良反应。采用重复测量资料的方差分析比较奎硫平和利培酮治疗首发精神分裂症的起效快慢及疗效。结果在研究中,分组与时间之间未见交互作用,差异无统计学意义(P>0.05);4周末的疗效、药物不良反应之间差异均无统计学意义(P>0.05)。结论两种药物治疗首发精神分裂症的起效时间和疗效相当,不良反应轻微,均安全有效。
出处 《重庆医学》 CAS CSCD 北大核心 2014年第4期411-413,共3页 Chongqing medicine
  • 相关文献

参考文献14

二级参考文献47

  • 1[1]Goldstein JM. Atypical antipsychotic drugs :beyond acute psychosis, new directions. Emerging Drugs, 1999,4:127
  • 2[2]Small JG, Hirsch SR, Arvanitis LA, et al. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group. Arch Gen Psychiatry,1997,54:549
  • 3[3]Borison RL, Arvanitis LA, Miller BG. ICI 204.636, an atypical antipsychotic: efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia. US Seroquel Study Group. J Clin Psychopharmacol, 1996,16:158
  • 4[4]Arvanitis LA,Miller BG and the Seroquel Trial 13 Group.Multiple fixed doses of "Seroquel"(quetiapine) in patients with acute exacerbation of schizophrenia:a comparison with haloperiadaol and placebo.Biol Psychiatry,1997,42:233
  • 5[5]Beasley CM,Sanger T,Satterlee W,et al.Olanzapine versus placebo:results of double-blind,fixed dose olanzapine trail.Psychopharmacology,1996,124:159
  • 6[6]Tran PV,Hamilton SH,Kuntz AJ,et al.Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders.J Clin Psychopharmacol,1997,17:407
  • 7[7]Kasper S,Muller-Spahn F.Review of quetiapine and its clinical applications in schizophrenia.Exp Opin Pharmacother,2000,1:783
  • 8[8]Purdon S,Malla A,Labelle A,et al.Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol.J Psychiatr Neurosci,2001,26:137
  • 9[9]Hellwell J,Mckeller M,Raniwalla J."Seroquel":efficacy in aggression,hostility and low mood of schizophrenia [abstract].Presented at the CINP Congress,1998,Glasgow UK
  • 10[10]Tariot PH,Salzman MD,Yeung PP,et al.Long-term use of quetiapine in elderly patients with psychotic disorders.Clin Ther,2000,22:1068

共引文献1060

同被引文献137

  • 1陆滨,陈桂兵,蔡则环.利培酮治疗精神分裂症疗效的纵向观察[J].临床心身疾病杂志,2009,13(23):182-183.
  • 2Solanki R K, Singh P, Munshi D. Current perspectives in the treat-ment of resistant schizophrenia[J]. Indian J Psychiatry, 2009, 51(4):254-260.
  • 3Zhong K X,Sweitzer D E, Hamer R M, et al. Comparison of que-tiapine and risperidone in the treatment of schizophrenia: a ran-domized,double-blind,flexible-dose,8-weekStudyP].JClinPsych-iatiy, 2006, 67(7):1093-1103.
  • 4Larmo I, D E Nayer A, Windhager E, et al. Efficacy and tolerabil-ity of quetiapine in patients with schizophrenia who switched fromhaloperidol, olanzapine or risperidone [J].Hum Psychopharmacol,2005, 20(8):573-581.
  • 5Altamura A C, Sassella F, Santini A, et al. Intramuscular prepa-rations of antipsychotics : uses and relevance in clinical practice [J].Drugs’ 2003, 63(5):493-512.
  • 6Francey S M,Nelson B, Thompson A, et al.Who needs antipsy-chotic medication in the earliest stages of psychosis? A reconsid-eration of benefits,risks,neurology and ethics in the era of earlyintervention [J]. Schizophr Res, 2010, 119(13):1-10.
  • 7EeantiS V, Mogg A J,Pluck G C, et al. Methohexitone,propofoland etomidate in electrOcOnvulsive therapy for depression natu-ralistic comparison study[J]. J Affect Disord, 2009,113(1-2):165-71.
  • 8John H,Sweta D,Jeffrey RB,et al.Association of DRD2 and ANKK1 polymorphisms w ith prolactin increase in olanzapinetreated w omen[J].Psychiatry Res,2011,187(1/2):74-79.
  • 9Basterreche N,Zumarraga M,Arrue A,et al.Aripiprazole reverses paliperidone-induced hyperprolactinemia[J].Actas Esp Psiquiatr,2012,40(5):90-92.
  • 10Rocha FL,Hara C,Ramos MG.Using aripiprazole to attenuate paliperidone-induced hyperprolactinemia[J].Prog Neuropsychopharmacol Biol Psychiatry,2010,34(6):1153-1154.

引证文献17

二级引证文献113

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部